101 papers
Understanding the human mind and treating mental health conditions requires a deep blend of biological insight and behavioral science. This category explores the cutting-edge research shaping how we diagnose and treat psychiatric disorders, from depression and anxiety to complex neurological conditions. Here, you will find the latest discoveries that bridge the gap between clinical observation and molecular mechanisms, offering fresh perspectives on patient care and therapeutic innovation.
Gist.Science brings these vital studies directly to you by monitoring medRxiv, the leading preprint server for health sciences. As soon as new manuscripts appear in this field, our team processes them to provide both accessible plain-language summaries and detailed technical overviews. This ensures that complex findings are understandable for everyone, from curious readers to busy professionals who need quick, accurate insights without wading through dense academic prose.
Below are the most recent psychiatry and clinical psychology preprints, curated and summarized to keep you informed on the evolving landscape of mental health research.
This study developed and validated a prediction model using elastic net logistic regression that integrates developmental trauma and trait responsiveness to verbal suggestion to effectively identify individuals at risk for dissociative psychopathology, achieving an AUROC of .77.
This study utilizes simultaneous PET-MRI and a novel individualized perturbation analysis to demonstrate that individuals at clinical high-risk for psychosis and those with first-episode psychosis exhibit significant disruptions in corticolimbic cerebral blood flow covariance, particularly at hippocampal edges, which are linked to altered relationships with GABAergic receptor availability.
This study of 598 children with rare genetic mutations (ND-CNVs) and their siblings reveals that while these families experience higher levels of both cohesion and conflict, positive family functioning—specifically greater cohesion and reduced hostility—significantly mitigates psychiatric symptoms such as oppositional defiant and mood disorders, highlighting the potential of family-centered interventions to improve outcomes.
This longitudinal study of 313 Brazilian healthcare postgraduate trainees during the COVID-19 pandemic found a very high incidence of burnout (202.9 per 1,000 person-years), identifying baseline depressive symptoms as the strongest predictor of future burnout and adequate professional training as a protective factor.
This diagnostic accuracy study evaluated a natural language processing-based AI model using 500 electronic health records from a psychiatric hospital in Colombia, demonstrating its high agreement in extracting clinical domains and its potential to improve the early detection of bipolar disorder among patients with affective diagnoses.
This Swedish study utilizes a socio-ecological framework to demonstrate that women's entry into pornography is not a matter of simple choice but rather a pathway shaped by the convergence of early violence, institutional betrayals, and structural vulnerabilities, necessitating trauma-informed care and material support rather than individualized blame.
By applying generative modeling to sleep-wake EEG data, this study identifies NMDA receptor hypofunction as a critical synaptic mechanism underlying thalamocortical dysfunction in 22q11.2 deletion syndrome and demonstrates the potential of *in silico* pharmacology to pinpoint receptor-level targets for intervention.
This study of Australian youth with emerging mood disorders reveals that reduced day-to-day variability in ambient light exposure during winter is the primary mediator of seasonal increases in depressive and negative symptoms, surpassing the contributions of sleep and activity patterns.
The TIDE study protocol outlines a prospective clinical cohort investigation designed to assess the feasibility of daily symptom tracking, estimate the prevalence of premenstrual exacerbation (PME) in women with depression, and explore its association with other hormone-related mood symptoms.
A pooled analysis of 536 psilocybin sessions across 14 studies reveals that the drug causes only modest, transient blood pressure elevations comparable to moderate exercise, suggesting that current cardiovascular exclusion criteria are overly conservative and should be broadened to include individuals with baseline blood pressure under 160/100 mmHg.